Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

501
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
501
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

36
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
36

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural correlates of foreign accent syndrome: Is white matter the key to the mystery?

Revue neurologique·2025
Same author

Surgical outcome of cerebral amyloid angiopathy-related cerebral hemorrhage-A multicenter comparative study.

Revue neurologique·2025
Same author

Neurological damage from recreational nitrous oxide use: Two distinct electroclinical profiles in a retrospective cohort.

Revue neurologique·2025
Same author

Prevalence and management of psychosis in an outpatient population with Parkinson's disease: A real-life descriptive study.

Revue neurologique·2025
Same author

Parkinson's Disease, Speech and Neurosurgery.

Brain and behavior·2025
Same author

Development of an Objective Structured Clinical Examination (OSCE) to evaluate the diagnosis announcement of chronic neurological disease by residents in neurology.

Revue neurologique·2024

Related Experiment Video

Updated: May 5, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

25.1K

Parkinson's patients cope with daylight saving time.

D Fetter1, R Lefaucheur1, A Borden1

  • 1Department of neurology, Rouen university hospital and university of Rouen, 1, rue de Germont, 76031 Rouen cedex, France.

Revue Neurologique
|November 19, 2013
PubMed
Summary

Daylight saving time (DST) shifts did not significantly impact Parkinson's disease (PD) symptoms, including motor fluctuations and non-motor issues. PD patients appear to adapt well to these circadian rhythm disruptions.

Keywords:
Daylight saving timeDepressive moodDécalage horaireDépressionExcessive daytime sleepinessFluctuations motricesMaladie de ParkinsonMotor fluctuationsParkinson's diseaseSommeil

More Related Videos

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

29.2K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.4K

Related Experiment Videos

Last Updated: May 5, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

25.1K
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

29.2K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.4K

Area of Science:

  • Neurology
  • Chronobiology
  • Sleep Medicine

Background:

  • Circadian rhythm disruptions from daylight saving time (DST) may affect Parkinson's disease (PD) symptom severity.
  • Understanding the impact of DST on PD patients is crucial for managing their condition.

Purpose of the Study:

  • To investigate the effects of DST transitions on motor and non-motor symptoms in Parkinson's disease patients.
  • To assess changes in "off-time", sleepiness, depression, and psychosis following DST.

Main Methods:

  • Eighty-three Parkinson's disease patients were evaluated before and after DST.
  • Key metrics included daily "off-time", Epworth Sleepiness Scale (ESS), Beck Depression Inventory (BDI), and Parkinson's Associated Psychosis (PAPD) scores.

Main Results:

  • No significant changes were observed in total daily "off-time", ESS, BDI, or PAPD scores after DST.
  • Individual patient data showed variability, but overall group results indicated stability.

Conclusions:

  • Parkinson's disease patients generally tolerate DST transitions without significant worsening of motor or non-motor symptoms.
  • The circadian system in PD patients may be resilient to the acute effects of DST.